InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the complete record of transactions filed by Carroll David Francis, Chief Financial Officer. Director active across 1 company, notably IVERIC bio, Inc.. Aggregated, 13 reports have been logged. Split: 0 buy · 3 sells. Total volume traded: €1.6m. History available since 21 December 2021. The latest transaction was filed on 1 April 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations13 total
2,144 shares@ US$17.002.0% of flowCommon StockSEC:0001410939-22-000046:0
16,763 shares@ US$1.451.3% of flowCommon StockSEC:0001410939-22-000033:0
8,237 shares@ US$1.450.6% of flowCommon StockSEC:0001410939-22-000024:0
32,500 sharesCommon StockSEC:0001104659-22-000976
32,500 sharesCommon StockSEC:0001104659-22-000976:0
56,207 shares@ US$15.9826100.0% of flowCommon StockSEC:0001104659-21-153088
56,207 shares@ US$15.982648.0% of flowCommon StockSEC:0001104659-21-153088:0
14,375 sharesCommon StockSEC:0001104659-21-152294
14,375 sharesCommon StockSEC:0001104659-21-152294:0
12,500 sharesCommon StockSEC:0001104659-21-149632:0
12,500 sharesCommon StockSEC:0001104659-21-149632
10,000 sharesCommon StockSEC:0001104659-21-149245:0
10,000 sharesCommon StockSEC:0001104659-21-149245
13 of 13 declarations
About Carroll David Francis
Carroll David Francis serves as Senior Vice President, Chief Financial Officer, and Treasurer at IVERIC bio, Inc. He is responsible for the company's financial management, including financial planning, treasury, and financial reporting. With extensive experience in the biopharmaceutical sector, he plays a key role in optimizing financial performance and the company's investment strategy.
